VYT — Vytrus Biotech SA Cashflow Statement
0.000.00%
Last trade - 00:00- €15.49m
- €16.46m
- €3.74m
- 69
- 20
- 38
- 34
Annual cashflow statement for Vytrus Biotech SA, fiscal year end - December 31st, millions except per share.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | ARS | ARS | ARS | |
| Standards: | — | SAS | SAS | SAS | SAS |
| Status: | fx Preliminary | Final | Final | Final | Final |
| Net Income/Starting Line | — | 0.092 | 0.309 | 0.453 | 0.308 |
| Depreciation | |||||
| Amortisation | |||||
| Non-Cash Items | — | -0.4 | -0.486 | -0.503 | 0.237 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | — | -0.218 | 0.049 | -0.416 | -0.366 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Other Assets | |||||
| Change in Payable / Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | — | -0.132 | 0.448 | 0.226 | 0.904 |
| Capital Expenditures | — | -0.235 | -0.272 | -0.494 | -1.17 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | — | -0.002 | -0.031 | -0.032 | -0.015 |
| Change in Net Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | — | -0.238 | -0.303 | -0.526 | -1.18 |
| Financing Cash Flow Items | — | -0.007 | -0.075 | — | — |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | — | 0.635 | 0.045 | -0.258 | 0.657 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | — | 0.265 | 0.19 | -0.559 | 0.38 |